![](/img/cover-not-exists.png)
CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature
Higashi-Kuwata, Nobuyo, Hayashi, Sanae, Das, Debananda, Kohgo, Satoru, Murakami, Shuko, Hattori, Shin-ichiro, Imoto, Shuhei, Venzon, David J., Singh, Kamalendra, Sarafianos, Stefan G., Tanaka, YasuhitJournal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/aac.02143-18
Date:
January, 2019
File:
PDF, 1.15 MB
2019